gout supplementary data appendix a

Upload: acoolz90

Post on 24-Feb-2018

212 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/25/2019 Gout Supplementary Data Appendix A

    1/1

    1

    Supplemental Appendix A:

    Conflict of interest (COI)

    Specific relationships with companies, and respective pharmaceuticals in use representing COI,

    were: URL Pharma (Colchicine); Takeda (Febuxostat); Amgen / Biovitrum / Sobi (Anakinra);

    Savient (Pegloticase). Specific relationships with companies, and respective pharmaceuticals inclinical trials representing COI, were: Celgene (Apremilast); AstraZeneca (AZD6140); BioCryst

    (BCX4208); Merck (Etoricoxib); Novartis (Canakinumab, Lumaricoxib); Ardea Biosciences

    (Lesurinad); Regeneron (Rilonacept); Glaxo Smith Kline and Nuon Therapuetics (Tranilast);EnzymeRx (Pegadricase).